Share Twitter LinkedIn Facebook Email Sattva S. Neelapu, MD, from the University of Texas MD Anderson Cancer Center discusses how Axi-Cel is a milestone for treating B-Cell Lymphoma and the paradigm shift for future B-Cell Lymphoma treatment at the 2017 American Society of Hematology.
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read
FDA Approves Inotuzumab Ozogamicin (BESPONSA) for Acute Lymphoblastic Leukemia in Pediatric Patients [Exclusive Video] Acute Lymphoblastic Leukemia 3 Mins Read